In a significant portfolio adjustment, Farallon Capital Management has completely divested its holdings in Cardinal Health. The major investment firm sold off its entire position of 368,000 shares, which was previously valued at $77.76 million and represented a 0.44% weight in its portfolio.
This trade information was disclosed in Farallon's public 13F filing on August 14, 2026, which details the firm's positions as of June 30, 2026. These quarterly reports offer a delayed look into institutional investment activities, meaning the decision to exit the Cardinal Health stake occurred during the second quarter of the year. During that period, Cardinal Health reported beating earnings per share estimates but missing on revenue.